BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 19882460)

  • 21. Structuring the review of human genetics protocols, Part II: diagnostic and screening studies.
    Glass KC; Weijer C; Lemmens T; Palmour RM; Shapiro SH
    IRB; 1997; 19(3-4):1-13. PubMed ID: 11656943
    [No Abstract]   [Full Text] [Related]  

  • 22. HIV vaccine trials: reconsidering the therapeutic misconception and the question of what constitutes trial related injuries.
    Schüklenk U; Ashcroft R
    Dev World Bioeth; 2007 Dec; 7(3):ii-iv. PubMed ID: 18021115
    [No Abstract]   [Full Text] [Related]  

  • 23. Is there coercion or undue inducement to participate in health research in developing countries? An example from Rakai, Uganda.
    Nalugoda F; Wagman J; Kiddugavu M; Kiwanuka N; Garrett E; Gray RH; Serwadda D; Wawer MJ; Emanuel EJ
    J Clin Ethics; 2009; 20(2):141-9. PubMed ID: 19554819
    [No Abstract]   [Full Text] [Related]  

  • 24. Rethinking research ethics.
    Rhodes R
    Am J Bioeth; 2005; 5(1):7-28. PubMed ID: 16036651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multicenter trials and subject eligibility: should local IRBs play a role?
    Freedman B
    IRB; 1994; 16(1-2):1-6. PubMed ID: 11652320
    [No Abstract]   [Full Text] [Related]  

  • 26. Ethical issues in HIV vaccine trials in South Africa.
    Slack C; Lindegger G; Vardas E; Richter L; Strode A; Wassenaar D
    S Afr J Sci; 2000 Jun; 96():291-5. PubMed ID: 11863014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Views of the process and content of ethical reviews of HIV vaccine trials among members of US institutional review boards and South African research ethics committees.
    Klitzman R
    Dev World Bioeth; 2008 Dec; 8(3):207-18. PubMed ID: 19046258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Initial strategies for integrating buprenorphine into HIV care settings in the United States.
    Sullivan LE; Bruce RD; Haltiwanger D; Lucas GM; Eldred L; Finkelstein R; Fiellin DA
    Clin Infect Dis; 2006 Dec; 43 Suppl 4():S191-6. PubMed ID: 17109306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ethics of research involving mandatory drug testing of high school athletes in Oregon.
    Shamoo AE; Moreno JD
    Am J Bioeth; 2004; 4(1):25-31. PubMed ID: 15035935
    [TBL] [Abstract][Full Text] [Related]  

  • 30. International guidelines for ethical review of epidemiological studies.
    Law Med Health Care; 1991; 19(3-4):247-58. PubMed ID: 1779694
    [No Abstract]   [Full Text] [Related]  

  • 31. The dirty little truth: we want them to understand, but not really..
    Morreim H
    Am J Bioeth; 2009 Feb; 9(2):9-11. PubMed ID: 19180381
    [No Abstract]   [Full Text] [Related]  

  • 32. The limitations of "vulnerability" as a protection for human research participants.
    Levine C; Faden R; Grady C; Hammerschmidt D; Eckenwiler L; Sugarman J;
    Am J Bioeth; 2004; 4(3):44-9. PubMed ID: 16192138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exception from informed consent: viewpoint of institutional review boards--balancing risks to subjects, community consultation, and future directions.
    Ernst AA; Fish S
    Acad Emerg Med; 2005 Nov; 12(11):1050-5. PubMed ID: 16264073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An IRB member's perspective on access to innovative therapy.
    Moore DL
    Albany Law Rev; 1994; 57(3):559-81. PubMed ID: 11652854
    [No Abstract]   [Full Text] [Related]  

  • 35. Issues related to the protection of human research participants.
    Harrison L
    J Neurosurg Nurs; 1993 Jun; 25(3):187-93. PubMed ID: 11660053
    [No Abstract]   [Full Text] [Related]  

  • 36. Power, advocacy, and informed consent forms.
    Smith ML
    J Calif Alliance Ment Ill; 1994; 5(1):25-7. PubMed ID: 11653311
    [No Abstract]   [Full Text] [Related]  

  • 37. Cultural feasibility studies in preparation for clinical trials to reduce maternal-infant HIV transmission in Haiti.
    Coreil J; Losikoff P; Pincu R; Mayard G; Ruff AJ; Hausler HP; Desormeau J; Davis H; Boulos R; Halsey NA
    AIDS Educ Prev; 1998 Feb; 10(1):46-62. PubMed ID: 9505098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disclosing clinical trial results: publicity, significance and independence.
    Liao SM; Sheehan M; Clarke S
    Am J Bioeth; 2009 Aug; 9(8):W3-5. PubMed ID: 19998144
    [No Abstract]   [Full Text] [Related]  

  • 39. Adolescents as doubly-vulnerable research subjects.
    Kopelman LM
    Am J Bioeth; 2004; 4(1):50-2. PubMed ID: 15035950
    [No Abstract]   [Full Text] [Related]  

  • 40. The concept of the IRB and bureaucratic reality: an exchange of letters.
    van Eys J; Levine RJ
    IRB; 1984; 6(4):8-10. PubMed ID: 11649563
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.